Ratings
Negative
HUBG Q2 Deep Dive: Revenue Miss and Cautious Outlook as Tariffs and Demand Weigh
Breaking news from global financial markets
2 months ago
Read More
2 months ago
3,210
2 months ago
2,138
2 months ago
1,321
2 months ago
3,145
2 months ago
1,084
2 months ago
2,894
2 months ago
3,532
2 months ago
1,368
2 months ago
2,783
2 months ago
1,926
2 months ago
956
2 months ago
3,569
2 months ago
4,606
2 months ago
3,052
2 months ago
1,264
2 months ago
1,722
2 months ago
4,937
2 months ago
973
Elevance Health, Inc. (ELV) Reports Q2 2025 Results; Mizuho Maintains ‘Buy’ Rating With $342 PT
Ratings
2 months ago
2,050
Trending Now
1
Synopsys, Inc. (SNPS) Investors with Substantial Losses Have Opportunity to Lead...
34,505
17 minutes ago
2
Notable analyst calls this week: Charter, Datadog and Palantir among top picks
26,768
30 minutes ago
3
Nvidia Stock’s Path to $350. Could Such a Rally Pressure Burry to Close His Bet?
32,284
32 minutes ago
4
2 No-Brainer Dividend Stocks to Buy With $100 in November
49,676
52 minutes ago
5
Lundin Gold (TSX:LUG): Exploring Valuation After Recent Share Price Surge
22,077
53 minutes ago